Understanding patient participation in treatment-resistant depression
Part of Mental health clinical trials.
This study looks at how people with treatment-resistant depression engage in their care. It does not test a new treatment but aims to understand patterns, which may help improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with treatment-resistant depression.
- You are 18 years old or older.
- You are able to understand and sign a consent form.
- You have not yet received any treatment specifically for treatment-resistant depression.
- You are not currently participating in another research study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using brain-related “biomarkers” from your scans to guide rTMS can improve depression that hasn’t responded to at least one antidepressant. It may help by targeting brain circuits linked to depression more precisely.
This study looks at how the brain's frontal lobe (DLPFC) works during memory tasks in people with treatment-resistant depression. It compares brain activity between depressed patients and healthy controls using MRI and possibly a brain stimulation technique (rTMS). It aims to understand why some people don't respond to standard treatments.
This study tests whether a psilocybin-based treatment can help people with depression that has not improved after trying several antidepressants. You will receive the study treatment and have brain scans to see how it affects brain connections.
This study is looking at people with mood disorders like depression or bipolar disorder to better understand their experiences. By joining, you can help researchers learn more about these conditions, which may lead to better care in the future.
This Phase 2 study tests BPL-003 in people with treatment-resistant depression to learn about its safety and how it affects the body and brain. Because it is open-label, everyone knows they are getting the study treatment, and you’ll also need to stop your current antidepressant during the study.
This study tests a computer-based tool to help choose the next medication for older adults with stubborn depression. It may help match you with a treatment (aripiprazole or bupropion) that is more likely to work for you.
Hear when a new Treatment Resistant Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.